[REVISION HISTORY]
Thermo Fisher institutional stake shifts
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-08-06 08:12 UTC → 2026-08-07 22:02 UTC ·
added
removed
Thermo Fisher institutional stake cuts shifts
In late July 2026, 2026 First Trust Advisors LP disclosed a 37.9% reduction in its Thermo Fisher Scientific holdings, trimming its position to about 43,500 shares worth valued at roughly $21 million. The same filing noted that Thermo Fisher’s million, and the company’s chief operating officer, Gianluca Pettiti, sold 400 shares under a Rule 10b5‑1 plan, decreasing his personal stake to about 24,600 shares. plan. A week later, later Edgestream Partners L.P. reported a far larger divestiture, selling sold most of its Thermo Fisher position—1,763 shares—leaving stake, retaining only 645 shares (about $317,000) and after a 73.2% drop from its prior holding. cut. The firm also July 28 filing reiterated First Trust’s cut its stake in Merck & Co., disposing of nearly 20,000 shares and retaining a modest balance. Both filings illustrate a pattern of institutional investors scaling back exposure to Pettiti’s insider sale, confirming the earlier trend. On August 6, Sarasin & Partners LLP moved in the opposite direction, increasing its Thermo Fisher position by 6.8% to 266,872 shares (about $133.8 million), while UMB Financial Corporation director Susan Murphy sold 1,377 shares, reducing her personal holding by 11.5%. The mixed activity shows that while several institutions continued to scale back exposure, at least one major investor expanded its stake, highlighting divergent views on the company’s outlook during the first quarter half of 2026.
Versions
- 2026-08-07 22:02 UTC Thermo Fisher institutional stake shifts
- 2026-08-06 08:12 UTC Thermo Fisher institutional stake cuts
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.